TP53 and neoplasm: In contrast to NVP-CGM097, HDM201 intermittent pulse high-dose treatment can induce PUMA (p53 upregulated modulator of apoptosis) expression and apoptosis in the preclinical model to achieve in vivo anti-tumor activity [80].